Loading...
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
Androgen deprivation therapy (ADT) is a cornerstone of treatment for prostate cancer and, in recent years, androgen receptor (AR)-targeted therapies (abiraterone and enzalutamide) have both been used for the treatment of castration-resistant prostate cancer (CRPC). In our study, we sought to investi...
Na minha lista:
| Udgivet i: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356925/ https://ncbi.nlm.nih.gov/pubmed/32580478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061950 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|